Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced today that Stan Jacot, president and CEO and T.J. Schaefer, CFO, will be participating in two investor conferences during the month of September.
- H.C. Wainwright 25th Annual Global Investment Conference. Arcadia will be featured as a presenting company at the conference, to be held September 11-13, 2023 at the Lotte Palace Hotel in New York City. Stan Jacot, Arcadia’s president and CEO will present a business overview at 4:00 p.m. ET on Tuesday, September 12 and will be available for in-person meetings with investors. Institutional investors may request a meeting by registering for the conference at www.hcwevents.com/annualconference.
- Lake Street Capital Markets’ 7th Annual Best Ideas Growth (BIG7) Conference. Arcadia will also be conducting one-on-one investor meetings at Lake Street’s BIG7 Conference on Thursday, September 14, 2023 at the Yale Club in New York City.
About Arcadia Biosciences
Since 2002, Arcadia Biosciences (Nasdaq: RKDA) has been innovating crops to provide high-value, healthy ingredients to meet consumer demands for healthier choices. With its roots in agricultural innovation, Arcadia cultivates next-generation wellness products that make every body feel good. The company’s food and beverage products include GoodWheat™ pasta and pancake mixes and Zola® coconut water. For more information, visit www.arcadiabio.com.
Arcadia Biosciences Contact: